• Lyso-Tracker Red for Live-Cell Lysosome Assays

  2026-08-22

  Lyso-Tracker Red enables rapid, live-cell visualization of acidic lysosomes for microscopy, flow cytometry, and nanozyme mechanism studies. Its nanomolar workflow supports dynamic compartment tracking without the fixed-cell limitations of conventional endpoint stains.

• Vasopressin Analogues: From Hormones to Therapeutics

  2026-08-21

  Glavaš and colleagues present a literature-based framework connecting vasopressin biology with the design of natural, synthetic, and non-peptide analogues. The review shows how receptor selectivity, proteolytic stability, duration of action, and route of administration shape applications ranging from treatment of diabetes insipidus to hemostatic and investigational antiviral research.

• Bestatin Hydrochloride and Angiotensin III in Rat Brain

  2026-08-20

  Harding and Felix used selective aminopeptidase inhibition, iontophoretic peptide delivery, and neuronal recording to test whether angiotensin II must be converted to angiotensin III before activating rat brain neurons. Their results placed aminopeptidase-dependent peptide processing at the center of central angiotensin signaling and provide a useful pharmacological framework for interpreting Bestatin hydrochloride and Ubenimex experiments.

• AM 281: Decoding CB1–CREB–GLT-1 Signaling

  2026-08-20

  AM 281 is a selective CB1 cannabinoid receptor antagonist for dissecting how endocannabinoid signaling influences glutamate homeostasis and cognitive dysfunction. This article translates recent traumatic brain injury findings into practical assay-design decisions, with emphasis on temporal sampling, astrocyte readouts, and pharmacological interpretation.

• CCT007093: PPM1D Inhibitor Workflows

  2026-08-19

  CCT007093 is a research-grade PPM1D inhibitor for connecting WIP1 phosphatase activity with p38 signaling, cell viability, and inflammatory cell death. Its DMSO-based handling, pathway-rescue controls, and paired cancer–kidney workflows support more rigorous target-mechanism studies.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-19

  Oh et al. developed a scalable human induced pluripotent stem cell system that rapidly generates functional sensory neurons and supports experimentally defined HSV-1 latency and reactivation. The model combines neuronal validation with virological, transcriptional, and chromatin-based readouts, providing a human-relevant platform for studying latency mechanisms and reactivation triggers.

• Sodium Picosulfate in Cell Assay Workflows

  2026-08-18

  Learn how Sodium Picosulfate SKU B2027 can be incorporated into reproducible cell viability, proliferation, and cytotoxicity workflows without confusing formulation effects with biological toxicity. This scenario-driven guide covers controls, solvent calculations, exposure design, interpretation, and practical product selection.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-08-18

  The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric approach for measuring functional SOD activity in biological fluids through inhibition of WST-1 reduction. It is intended for research workflows, not diagnosis, medical decision-making, direct hydrogen peroxide measurement, or cell-imaging applications.

• ALDH2 Activator Z17 in Myocardial Ischemia

  2026-08-17

  The 2025 ACS Medicinal Chemistry Letters study used molecular simulation and structure optimization to discover triazole-based ALDH2 activators with improved activity and water solubility. Its representative compound Z17 enhanced cardiac function and reduced biochemical and histological indicators of myocardial ischemia-reperfusion injury in mice, supporting ALDH2 as a drug-development target while leaving important translational questions unresolved.

• Latrunculin B: Mechanism Meets Assay Design

  2026-08-17

  Latrunculin B is a cell-permeable actin polymerization inhibitor whose transient behavior makes timing central to experimental interpretation. This evidence-led guide connects molecular mechanism with cytoskeletal assays and explains why a negative latrunculin B result in viral-entry research can be scientifically informative.

• Viral RIPK3 Degradation Controls Inflammation

  2026-08-16

  Liu and colleagues identified vIRD, a viral inducer of RIPK3 degradation that links orthopoxvirus immune evasion to SCF ubiquitin machinery and proteasomal control of necroptosis. The study shows that vIRD–RIPK3 interactions can reshape viral replication, inflammation, and mortality in a context-dependent manner, providing a framework for interpreting pathogen–host coevolution.

• Perifosine (KRX-0401) Experimental Workflow Guide

  2026-08-15

  Build more informative Akt pathway experiments with Perifosine (KRX-0401), from concentration-response apoptosis assays to mechanistic OGD/R studies and radiation sensitization in cancer cells. This guide separates product-supported findings from practical pilot conditions, helping researchers interpret pathway inhibition without overextending evidence across disease models.

• Deferasirox Fe3+ Chelate in Lysosome Stress

  2026-08-15

  Deferasirox Fe3+ chelate offers a precise way to examine ferric-iron availability within nutrient-stress and lysosomal cell-death models. This article connects Exjade-related iron chelation research with the TCF25–V-ATPase–ferritinophagy pathway while defining assay controls and important translational limits.

• AA263 Analogs Rewire ER Proteostasis

  2026-08-14

  This bioRxiv study identifies a covalent interaction between the phenylhydrazone compound AA263 and a subset of endoplasmic reticulum protein disulfide isomerases, providing a mechanistic basis for ATF6 activation. Medicinally optimized analogs showed stronger activity and improved secretory-pathway proteostasis in models of alpha-1-antitrypsin and GABAA receptor misfolding.

• Temafloxacin Workflow for Antibacterial Assays

  2026-08-13

  Build reproducible MIC, checkerboard, growth-curve, and intracellular infection workflows with Temafloxacin BA1108. The guide separates evidence-backed parameters from practical optimization, helping researchers evaluate broad-spectrum activity without overinterpreting combination effects.

450 records 7/30 page Previous Next First page 上5页 678910 下5页 Last page